Patient perspectives on factors influencing active surveillance adherence for low-risk prostate cancer: A qualitative study

被引:1
|
作者
Subramanian, Lalita [1 ]
Hawley, Sarah T. [1 ,2 ]
Skolarus, Ted A. [2 ,3 ]
Rankin, Aaron [1 ]
Fetters, Michael D. [4 ]
Witzke, Karla [5 ]
Chen, Jason [1 ]
Radhakrishnan, Archana [1 ,2 ,6 ]
机构
[1] Univ Michigan, Dept Internal Med, Ann Arbor, MI 48109 USA
[2] VA Ann Arbor Healthcare Syst, Ctr Clin Management Res, Hlth Serv Res & Dev, Ann Arbor, MI USA
[3] Univ Chicago, Dept Surg, Urol Sect, Chicago, IL USA
[4] Univ Michigan, Dept Family Med, Ann Arbor, MI 48109 USA
[5] MyMichigan Hlth, Dept Urol, Midland, MI USA
[6] Univ Michigan, Dept Internal Med, Div Gen Med, Internal Med, Ann Arbor, MI 48109 USA
来源
CANCER MEDICINE | 2024年 / 13卷 / 01期
关键词
active surveillance; primary care physicians; prostate cancer; quality of life; trust; urologists; MEN; CRITERIA;
D O I
10.1002/cam4.6847
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
BackgroundProstate cancer is the most common cancer among men in the United States. Treatment guidelines recommend active surveillance for low-risk prostate cancer, which involves monitoring for progression, to avoid or delay definitive treatments and their side effects. Despite increased uptake, adherence to surveillance remains a challenge.MethodsWe conducted semi-structured, qualitative, virtual interviews based on the Theoretical Domains Framework (TDF), with men (15) who were or had been on active surveillance for their low-risk prostate cancer in 2020. Interviews were transcribed and coded under TDF's behavioral theory-based domains. We analyzed domains related to adherence to surveillance using constructivist grounded theory to identify themes influencing decision processes in adherence.ResultsThe TDF domains of emotion, beliefs about consequences, environmental context and resources, and social influences were most relevant to surveillance adherence-. From these four TDF domains, three themes emerged as underlying decision processes: trust in surveillance as treatment, quality of life, and experiences of self and others. Positive perceptions of these three themes supported adherence while negative perceptions contributed to non-adherence (i.e., not receiving follow-up or stopping surveillance). The relationship between the TDF domains and themes provided a theoretical process describing factors impacting active surveillance adherence for men with low-risk prostate cancer.ConclusionsMen identified key factors impacting active surveillance adherence that provide opportunities for clinical implementation and practice improvement. Future efforts should focus on multi-level interventions that foster trust in surveillance as treatment, emphasize quality of life benefits and enhance patients' interpersonal experiences while on surveillance to optimize adherence. Decision processes related to staying on or stopping active surveillance for prostate cancer involved trust in active surveillance as treatment, quality of life and experiences of self and others. Positive perceptions of these three themes supported adherence while negative perceptions contributed to non-adherence.image
引用
收藏
页数:11
相关论文
共 50 条
  • [1] CHARACTERIZING PATIENT PERSPECTIVES ON FACTORS IMPACTING BEING ON ACTIVE SURVEILLANCE FOR LOW-RISK PROSTATE CANCER
    Johnson, Shannon
    Hawley, Sarah
    Rankin, Aaron J.
    Skolarus, Ted A.
    Radhakrishnan, Archana
    JOURNAL OF GENERAL INTERNAL MEDICINE, 2023, 38 : S236 - S236
  • [2] Patient Factors That Influence How Physicians Discuss Active Surveillance With Low-Risk Prostate Cancer Patients: A Qualitative Study
    Brooks, Joanna Veazey
    Ellis, Shellie D.
    Morrow, Emily
    Kimminau, Kim S.
    Thrasher, J. Brantley
    AMERICAN JOURNAL OF MENS HEALTH, 2018, 12 (05) : 1719 - 1727
  • [3] Factors That Influence Patient Enrollment in Active Surveillance for Low-risk Prostate Cancer
    Gorin, Michael A.
    Soloway, Cynthia T.
    Eldefrawy, Ahmed
    Soloway, Mark S.
    UROLOGY, 2011, 77 (03) : 588 - 591
  • [4] Patient and Context Factors in the Adoption of Active Surveillance for Low-Risk Prostate Cancer
    Ciccone, Giovannino
    De Luca, Stefano
    Oderda, Marco
    Munoz, Fernando
    Krengli, Marco
    Allis, Simona
    Baima, Carlo Giuliano
    Barale, Maurizio
    Bartoncini, Sara
    Beldi, Debora
    Bellei, Luca
    Bellissimo, Andrea Rocco
    Bernardi, Diego
    Biamino, Giorgio
    Billia, Michele
    Borsa, Roberto
    Cante, Domenico
    Castelli, Emanuele
    Cattaneo, Giovanni
    Centrella, Danilo
    Collura, Devis
    Coppola, Pietro
    Dalmasso, Ettore
    Di Stasio, Andrea
    Fasolis, Giuseppe
    Fiorio, Michele
    Garibaldi, Elisabetta
    Girelli, Giuseppe
    Griffa, Daniele
    Guercio, Stefano
    Migliari, Roberto
    Molinaro, Luca
    Montefiore, Franco
    Montefusco, Gabriele
    Moroni, Maurizio
    Muto, Giovanni
    di Sant'Angelo, Francesca Ponti
    Ruggiero, Luca
    Redda, Maria Grazia Ruo
    Serao, Armando
    Squeo, Maria Sara
    Stancati, Salvatore
    Surleti, Domenico
    Varvello, Francesco
    Volpe, Alessandro
    Zaramella, Stefano
    Zarrelli, Giovanni
    Zitella, Andrea
    Bollito, Enrico
    Gontero, Paolo
    JAMA NETWORK OPEN, 2023, 6 (10) : E2338039
  • [5] Factors Influencing Men Undertaking Active Surveillance for the Management of Low-Risk Prostate Cancer
    Davison, B. Joyce
    Oliffe, John L.
    Pickles, Tom
    Mroz, Lawrence
    ONCOLOGY NURSING FORUM, 2009, 36 (01) : 89 - 96
  • [6] Optimizing active surveillance for low-risk prostate cancer: Characterizing provider and patient perspectives
    Radhakrishnan, Archana
    Subramanian, Lalita
    Rankin, Aaron
    Skolarus, Ted A.
    Wittmann, Daniela
    Hawley, Sarah T.
    Fetters, Michael
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (28)
  • [7] Patient and physician perspectives on treatments for low-risk prostate cancer: a qualitative study
    Guan, Alice
    Santiago-Rodriguez, Eduardo J.
    Chung, Benjamin I.
    Shim, Janet K.
    Allen, Laura
    Kuo, Mei-Chin
    Lau, Kathie
    Loya, Zinnia
    Brooks, James D.
    Cheng, Iona
    Derouen, Mindy C.
    Frosch, Dominick L.
    Golden, Todd
    Leppert, John T.
    Lichtensztajn, Daphne Y.
    Lu, Qian
    Oh, Debora
    Sieh, Weiva
    Wadhwa, Michelle
    Cooperberg, Matthew R.
    Carroll, Peter R.
    Gomez, Scarlett L.
    Shariff-Marco, Salma
    BMC CANCER, 2023, 23 (01)
  • [8] Patient and physician perspectives on treatments for low-risk prostate cancer: a qualitative study
    Alice Guan
    Eduardo J. Santiago-Rodríguez
    Benjamin I. Chung
    Janet K. Shim
    Laura Allen
    Mei-Chin Kuo
    Kathie Lau
    Zinnia Loya
    James D. Brooks
    Iona Cheng
    Mindy C. DeRouen
    Dominick L. Frosch
    Todd Golden
    John T. Leppert
    Daphne Y. Lichtensztajn
    Qian Lu
    Debora Oh
    Weiva Sieh
    Michelle Wadhwa
    Matthew R. Cooperberg
    Peter R. Carroll
    Scarlett L. Gomez
    Salma Shariff-Marco
    BMC Cancer, 23
  • [9] Active surveillance for low-risk prostate cancer
    Klotz, Laurence
    CURRENT OPINION IN UROLOGY, 2017, 27 (03) : 225 - 230
  • [10] Active surveillance for low-risk prostate cancer
    Herlemann, Annika
    Stief, Christian G.
    UROLOGE, 2016, 55 (02): : 269 - 278